Finely crafted investments

 

Amati in the Press

* registration required
DateDescription
25/02/2021 “Healthcare will be more important in the next decade than it was going into the pandemic,” Dr Paul Jourdan speaks to What Investment.
24/02/2021 “Amati launches strategic metals fund for top resources team” reports Citywire.
23/02/2021 TB Amati UK Smaller Companies Fund highlighted in Interactive Investor as a potential fund opportunity.
23/02/2021 * “Amati AIM VCT Top-Up Offer sells out in 90 minutes,” highlights Managers of Wealth.
12/02/2021 Square Mile talk with Dr Paul Jourdan
08/02/2021 'New technologies are going to continue to make a huge impact over the coming decade', Dr Paul Jourdan speaks to AIC.
08/02/2021 Dr Paul Jourdan offers his views to Citywire on vaccines, HeiQ and ESG
05/02/2021 Financial Times quote Dr Paul Jourdan on copper mining stock Atalaya.
01/02/2021 TB Amati UK Smaller Companies Fund highlighted in Investment Week's article on the AIM boom
19/01/2021 Dr Paul Jourdan speaks to Citywire on ESG credentials.
14/01/2021 "Antivax, risk & regulatory revolution" - Dr Paul Jourdan speaks to New Model Adviser in this healthcare special podcast.
13/01/2021 Trustnet list TB Amati UK Smaller Companies Fund as one of the top-performing UK funds since the Brexit vote.
11/01/2021 Dr Paul Jourdan speaks to Investment Week for their article "Corporate responsibility to be key focus for ESG investors in 2021"
09/01/2021 Dr Paul Jourdan quoted in This is Money's article in relation to the company Oxford Biomedica
04/01/2021 TB Amati UK Smaller Companies Fund highlighted as one of the top five best performers in December 2020, reports Morningstar.